IMMUNE DESIGN CORP's ticker is IMDZ and the CUSIP is 45252L103. A total of 66 filers reported holding IMMUNE DESIGN CORP in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $193,000 | +109.8% | 32,983 | +62.5% | 0.01% | +83.3% |
Q2 2018 | $92,000 | +384.2% | 20,302 | +968.5% | 0.01% | +200.0% |
Q2 2017 | $19,000 | +375.0% | 1,900 | +216.7% | 0.00% | – |
Q1 2017 | $4,000 | 0.0% | 600 | -11.9% | 0.00% | – |
Q4 2016 | $4,000 | -42.9% | 681 | -14.9% | 0.00% | -100.0% |
Q2 2016 | $7,000 | – | 800 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Versant Venture Management, LLC | 2,208,210 | $16,738,232,000 | 18.66% |
ProQuest Associates IV LLC | 1,962,720 | $14,877,000 | 4.10% |
BVF INC/IL | 1,200,000 | $9,096,000 | 1.71% |
Abingworth LLP | 197,300 | $1,494,000 | 1.43% |
NEXTHERA CAPITAL LP | 305,000 | $2,312,000 | 1.42% |
Cormorant Asset Management, LP | 432,990 | $3,282,000 | 0.36% |
SPHERA FUNDS MANAGEMENT LTD. | 203,000 | $1,539,000 | 0.25% |
DAFNA Capital Management LLC | 40,000 | $303,000 | 0.21% |
Monashee Investment Management LLC | 50,000 | $379,000 | 0.13% |
Eventide Asset Management | 180,000 | $1,364,000 | 0.08% |